Article

HCMV control in allogeneic stem cell transplant recipients - an analysis of humoral and cellular players beyond antigen-specific T cells in the letermovir era

2025-04-16

Abstract excerpt

Allogeneic hematopoietic stem cell transplant (alloSCT) recipients often experience late-onset human cytomegalovirus (HCMV) reactivations following termination of letermovir prophylaxis. Letermovir prophylaxis extends the window for protective B- and T-cell reconstitution; however, our understanding of humoral responses and their contribution to HCMV immune control remains limited. Combining serological and flow c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0daf13b1-6587-5d4b-ab43-e8188fd44545
DOI: 10.1101/2025.04.14.25325799

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HCMV control in allogeneic stem cell transplant recipients - an analysis of humoral and cellular players beyond antigen-specific T cells in the letermovir eraDOI 10.1101/2025.04.14.25325799Read

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cellsSemantic proximity Read

CMV Status Drives Distinct Trajectories of CD4+ T Cell DifferentiationSemantic proximity Read

Deep Profiling of the CD8+ T-cell Compartment Identifies Activated Cell Subsets and Multifunctional Responses Associated With Control of Cytomegalovirus Viremia.Semantic proximity Read

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantationSemantic proximity Read

CMV-specific clonal expansion in human Th1 and GZMK⁺ CD8⁺ T cellsSemantic proximity Read

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent functionSemantic proximity Read

Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCTSemantic proximity Read

The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.Semantic proximity Read

CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantationSemantic proximity Read

Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantationSemantic proximity Read

Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting LandscapeSemantic proximity Read

Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation.Semantic proximity Read